Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Crism Thera (CRTX) Share Price

Price 10.50p on 15-08-2025 at 05:00:02
Change 0.00p 0%
Buy 0.00p
Sell 0.00p
Last Trade: Sell 1,619.00 at 10.13p
Day's Volume: 0
Last Close: 10.50p
Open: 0.00p
ISIN: VGG042401262
Day's Range 0.00p - 0.00p
52wk Range: 6.25p - 29.00p
Market Capitalisation: £4.20m
VWAP: 0.00p
Shares in Issue: 39.96m

Crism Thera (CRTX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 1,619 10.13p Ordinary
15:37:01 - 13-Aug-25
Sell* 1,128 10.13p Ordinary
14:33:08 - 13-Aug-25
Sell* 7,373 10.20p Ordinary
11:31:22 - 13-Aug-25
Sell* 634 10.40p Ordinary
11:09:11 - 13-Aug-25
Sell* 1,000 10.20p Ordinary
09:04:22 - 12-Aug-25
Sell* 1,389 10.47p Ordinary
08:03:27 - 12-Aug-25
Sell* 1,000 10.47p Ordinary
08:00:16 - 12-Aug-25
Sell* 37,075 10.20p Ordinary
15:58:06 - 11-Aug-25
Sell* 4,731 10.57p Ordinary
12:46:06 - 11-Aug-25
Sell* 5 10.50p Ordinary
08:34:10 - 11-Aug-25
See more Crism Thera trades

Crism Thera (CRTX) Share Price History

Time period:
to
Date Open High Low Close Volume
14th Aug 2025 (Thu) 10.50 10.50 10.50 10.50 0
13th Aug 2025 (Wed) 10.50 10.50 10.50 10.50 10,754
12th Aug 2025 (Tue) 10.50 10.75 10.50 10.50 3,389
11th Aug 2025 (Mon) 10.75 10.75 10.50 10.50 46,483
8th Aug 2025 (Fri) 10.75 10.75 10.75 10.75 4,231
7th Aug 2025 (Thu) 10.75 10.75 10.75 10.75 5,080
6th Aug 2025 (Wed) 10.75 10.75 10.75 10.75 985
5th Aug 2025 (Tue) 10.75 10.75 10.75 10.75 10,125
4th Aug 2025 (Mon) 10.75 10.75 10.75 10.75 303
1st Aug 2025 (Fri) 10.75 10.75 10.75 10.75 7,642
31st Jul 2025 (Thu) 10.75 10.75 10.75 10.75 12,180
30th Jul 2025 (Wed) 10.75 10.75 10.75 10.75 125
29th Jul 2025 (Tue) 10.75 10.75 10.75 10.75 10,644
28th Jul 2025 (Mon) 10.75 10.75 10.75 10.75 32,906
25th Jul 2025 (Fri) 11.00 11.00 10.75 10.75 108,311
24th Jul 2025 (Thu) 11.00 11.00 11.00 11.00 50,418
23rd Jul 2025 (Wed) 11.25 11.25 11.00 11.00 10,370
22nd Jul 2025 (Tue) 11.25 11.25 11.25 11.25 0
21st Jul 2025 (Mon) 11.25 11.25 11.25 11.25 26,594
18th Jul 2025 (Fri) 11.25 11.25 11.25 11.25 72,867
17th Jul 2025 (Thu) 11.25 11.25 11.25 11.25 0
16th Jul 2025 (Wed) 11.25 11.25 11.25 11.25 22,834
15th Jul 2025 (Tue) 11.25 11.25 11.25 11.25 9,787
See more Crism Thera price history

Crism Thera (CRTX) Regulatory News

Date Source Headline
12th Aug 2025 7:00 am RNS GMP Manufacture of ChemoSeed
4th Aug 2025 5:45 pm RNS Notice of AGM and EMI Option Plan
10th Jul 2025 3:04 pm RNS Holding(s) in Company
3rd Jul 2025 7:00 am RNS Result of Retail Offer and Additional Placing
1st Jul 2025 4:41 pm RNS-R Update presentation on the IMC platform
1st Jul 2025 7:00 am RNS Submission of CTA Application
30th Jun 2025 7:01 am RNS Retail Offer
30th Jun 2025 7:00 am RNS Placing
13th Jun 2025 7:00 am RNS Final Results for the year ended 31 December 2024
9th Jun 2025 7:00 am RNS-R Best Paper Award
See more Crism Thera regulatory news

Crism Thera (CRTX) Share News

LONDON MARKET MIDDAY: London mixed as mortgage data beats expectations

30th Jun 2025 12:01

(Alliance News) - London stocks were mixed at midday on Monday, as US tariff uncertainty continues to weigh on investor sentiment despite a data reading confirming UK economic growth at the start of the year. Read More

AIM WINNERS & LOSERS: MediaZest swings to profit, remains optimistic

30th Jun 2025 11:03

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday. Read More

CRISM Therapeutics hails progress in glioblastoma as loss widens

13th Jun 2025 09:43

(Alliance News) - CRISM Therapeutics Corp on Friday said it is confident in its prospects, citing progress in glioblastoma, as it reported an increased loss. Read More

CRISM Therapeutics sets up advisory board ahead of ChemoSeed trial

3rd Jun 2025 12:24

(Alliance News) - CRISM Therapeutics Corp on Tuesday said it has established a scientific advisory board as it prepares to submit a clinical trial application for its lead product, ChemoSeed. Read More

IN BRIEF: CRISM Therapeutics gets European patent for tumour therapy

19th Dec 2024 08:32

CRISM Therapeutics Corp - Surrey-headquartered pharmaceutical firm - Granted a European patent for its lead product ChemoSeed by the European Patent Office. This covers the manufacturing process for the preparation of chemotherapeutic drug implants and their use in therapy, particularly in treating brain tumours such as high grade glioma. ChemoSeed facilitates the local delivery of irinotecan directly to the brain tumour resection site, which allows the delivery of larger doses and reduces systemic concentrations. This alleviates traditional side effects for the patient. Read More

See more Crism Thera news
FTSE 100 Latest
Value9,177.24
Change0.00

Login to your account

Forgot Password?

Not Registered